CND Life Sciences: $13.5 Million Series A Closed For Neurodiagnostics Innovations
By Amit Chowdhry ● May 4, 2025
CND Life Sciences announced that it has raised $13.5 million in its Series A equity financing round, with $8.6 million in its most recent Series A3 offering. CND's latest Series A3 round included funding from existing investor groups like Cambrian Capital Partners, Tanis Ventures, Lupo Labs, Top Corner Capital, HonorHealth, Triana, Gold Bench Capital, and BlueStone Ventures, and from new investors Labcorp, MBX Capital, and Vilas Ventures.